Expansion strategies for human mesenchymal stromal cells culture under xeno-free conditions (2017)
- Authors:
- USP affiliated authors: TRAINA, FABÍOLA - FMRP ; COVAS, DIMAS TADEU - FMRP
- Unidade: FMRP
- DOI: 10.1002/btpr.2494
- Subjects: CULTURA DE CÉLULAS; PROLIFERAÇÃO CELULAR; CÉLULAS CULTIVADAS; GLICOSE; CARIOTIPAGEM; CORDÃO UMBILICAL
- Keywords: Mesenchymal cell
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Biotechnology Progress
- ISSN: 8756-7938
- Volume/Número/Paginação/Ano: v. 33, n. 5, p. 1358-1367, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
TOZETTI, Patrícia Aparecida et al. Expansion strategies for human mesenchymal stromal cells culture under xeno-free conditions. Biotechnology Progress, v. 33, n. 5, p. 1358-1367, 2017Tradução . . Disponível em: https://doi.org/10.1002/btpr.2494. Acesso em: 27 dez. 2025. -
APA
Tozetti, P. A., Caruso, S. R., Mizukami, A., Fernandes, T. R., Silva, F. B. da, Traina, F., et al. (2017). Expansion strategies for human mesenchymal stromal cells culture under xeno-free conditions. Biotechnology Progress, 33( 5), 1358-1367. doi:10.1002/btpr.2494 -
NLM
Tozetti PA, Caruso SR, Mizukami A, Fernandes TR, Silva FB da, Traina F, Covas DT, Orellana MD, Swiech K. Expansion strategies for human mesenchymal stromal cells culture under xeno-free conditions [Internet]. Biotechnology Progress. 2017 ; 33( 5): 1358-1367.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1002/btpr.2494 -
Vancouver
Tozetti PA, Caruso SR, Mizukami A, Fernandes TR, Silva FB da, Traina F, Covas DT, Orellana MD, Swiech K. Expansion strategies for human mesenchymal stromal cells culture under xeno-free conditions [Internet]. Biotechnology Progress. 2017 ; 33( 5): 1358-1367.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1002/btpr.2494 - Expansion strategies for human mesenchymal stromal cells culture under xeno‐free conditions
- Characterization of human AB serum for mesenchymal stromal cell expansion
- FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease
- YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]
- Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
Informações sobre o DOI: 10.1002/btpr.2494 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
